References
- Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1997; 335: 179–88
- Mohammed JR, Mohammed S, Pawluk LJ, Bucci DM, Baker NR, Davis B. Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum. J Lab Clin Med 1988; 122: 711–20
- Koller DY, Urbanek R, Goetz M. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. J Respir Crit Care Med 1995; 152: 629–33
- Koller DY, Goetz M, Eichler I, Urbanek R. Eosinophilic activation in cystic fibrosis. Thorax 1994; 49: 496–9
- Koller DY, Goetz M, Wojnarowski C, Eichler I. Relationship between disease severity and inflammatory markers in cystic fibrosis. Arch Dis Child 1996; 75: 498–501
- Zapletal, A, Samanek, M, Paul, T. Lung function in children and adolescents: methods and reference values. In:. H Herzog, editor. Progress in respiration research, vol. 22. Basel: Karger.
- Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5–40
- Döring G, Conway SP, Heujerman HGM, Hodson ME, Høiby N, Smyth A, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000; 16: 749–67
- Govan JRW, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microb Rev 1993; 60: 539–43
- Høiby N. Microbiology of lung infections in cystic fibrosis patients. Acta Paediatrica Scand Suppl 1982; 301: 33–54
- Rabin, HR, Butler, SM, Wohl, MEB, Geller, DE, Colin, AA, Schidlow, DV, , et al, on behalf of the Scientific Advisory Group and Investigators of the Epidemiologic Study of Cystic Fibrosis. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 2004;37:400–6.
- Olsson I, Olofsson T, Ohlsson K, Gustavsson A. Serum and plasma myeloperoxidase, elastase and lactoferrin content in acute myeloid leukemia. Scand J Haematol 1979; 22: 397–406
- Olsen RL, Little C. Purification and some properties of myeloperoxidase and eosinophil peroxidase from human blood. Biochem J 1983; 209: 781–7
- Olsen RL, Steigen TK, Holm T, Little C. Molecular forms of myeloperoxidase in human plasma. Biochem J 1986; 237: 559–65
- Redding GJ, Restuccia R, Cotton EK, Brooks JG. Serial changes in pulmonary functions in children hospitalized with cystic fibrosis. Am Rev Respir Dis 1982; 126: 31–6
- Regelmann WE, Elliott GR, Warwick WJ, Clawson CC. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than does bronchodilators and chest physiotherapy alone. Am Rev Respir Dis 1990; 141: 914–21
- Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111–8
- Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery B, et al. Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr 2001; 139: 359–65
- Ramsey, BW, Boat, TF, for the Consensus Group. Outcome measures for clinical trials in cystic fibrosis. J Pediatr 1994;124:177–92.
- Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150: 448–54
- Sagel SD, Sontag MK, Wagener JS, Kapsner RK, Osberg I, Accurso FJ. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis. J Pediatr 2002; 141: 811–7
- Ordonez CL, Henig NR, Mayer-Hamblett N, Accurso FJ, Burns JL, Chmiel JF, et al. Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 1471–5
- Ordonez CL, Kartashov AI, Wohl ME. Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis. J Pediatr 2004; 145: 689–92